Guyana vs Northern America: Proportion of the target population who received a 3rd dose of
Guyana
98.0%
in 2024
Northern America
84.0%
in 2024
Guyana rank
7th
Northern America rank
6th
Proportion of the target population who received a 3rd dose of over time
- Guyana
- Northern America
How they compare
Guyana currently reports 98.0% against 84.0% in Northern America, a difference of 14.0%.
That makes Guyana's figure about 1.2 times Northern America's.
The two have swapped places 5 times across 14 shared years of data; in 2011 it was Northern America ahead.
Guyana ranks 7th and Northern America ranks 6th of 157 countries.
Across the 2 decades both report, Guyana averaged higher in 1 and Northern America in 1.
Head to head by decade
| Decade | Guyana | Northern America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.4% | 91.3% | 1.9% | Northern America |
| 2020s | 95.8% | 83.2% | 12.6% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Guyana or Northern America?
- Guyana, at 98.0% against 84.0% in Northern America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Guyana and Northern America?
- 14.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Northern America?
- 14 years are reported by both, from 2011 to 2024.
- How do Guyana and Northern America rank globally for proportion of the target population who received a 3rd dose of?
- Guyana ranks 7th and Northern America ranks 6th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.